Natural Alternatives International (NAII) Competitors $2.74 0.00 (-0.18%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAII vs. CRBU, XCUR, EPIX, UNCY, SGMT, ADAG, ADVM, IGMS, LXEO, and CRBPShould you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Caribou Biosciences (CRBU), Exicure (XCUR), ESSA Pharma (EPIX), Unicycive Therapeutics (UNCY), Sagimet Biosciences (SGMT), Adagene (ADAG), Adverum Biotechnologies (ADVM), IGM Biosciences (IGMS), Lexeo Therapeutics (LXEO), and Corbus Pharmaceuticals (CRBP). These companies are all part of the "pharmaceutical products" industry. Natural Alternatives International vs. Caribou Biosciences Exicure ESSA Pharma Unicycive Therapeutics Sagimet Biosciences Adagene Adverum Biotechnologies IGM Biosciences Lexeo Therapeutics Corbus Pharmaceuticals Caribou Biosciences (NASDAQ:CRBU) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk. Does the MarketBeat Community believe in CRBU or NAII? Natural Alternatives International received 249 more outperform votes than Caribou Biosciences when rated by MarketBeat users. Likewise, 76.82% of users gave Natural Alternatives International an outperform vote while only 61.90% of users gave Caribou Biosciences an outperform vote. CompanyUnderperformOutperformCaribou BiosciencesOutperform Votes2661.90% Underperform Votes1638.10% Natural Alternatives InternationalOutperform Votes27576.82% Underperform Votes8323.18% Is CRBU or NAII more profitable? Natural Alternatives International has a net margin of -6.26% compared to Caribou Biosciences' net margin of -1,290.81%. Natural Alternatives International's return on equity of -9.36% beat Caribou Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Caribou Biosciences-1,290.81% -45.46% -38.07% Natural Alternatives International -6.26%-9.36%-4.82% Do insiders & institutionals believe in CRBU or NAII? 77.5% of Caribou Biosciences shares are owned by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are owned by institutional investors. 9.5% of Caribou Biosciences shares are owned by insiders. Comparatively, 20.9% of Natural Alternatives International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media favor CRBU or NAII? In the previous week, Caribou Biosciences had 6 more articles in the media than Natural Alternatives International. MarketBeat recorded 9 mentions for Caribou Biosciences and 3 mentions for Natural Alternatives International. Natural Alternatives International's average media sentiment score of 0.33 beat Caribou Biosciences' score of 0.22 indicating that Natural Alternatives International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caribou Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Natural Alternatives International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, CRBU or NAII? Caribou Biosciences has a beta of 2.36, indicating that its share price is 136% more volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Which has better earnings and valuation, CRBU or NAII? Natural Alternatives International has higher revenue and earnings than Caribou Biosciences. Natural Alternatives International is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCaribou Biosciences$9.99M6.84-$102.07M-$1.65-0.45Natural Alternatives International$121.85M0.14-$7.22M-$1.29-2.09 Do analysts rate CRBU or NAII? Caribou Biosciences currently has a consensus price target of $10.33, indicating a potential upside of 1,305.90%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Caribou Biosciences is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNatural Alternatives International beats Caribou Biosciences on 10 of the 18 factors compared between the two stocks. Get Natural Alternatives International News Delivered to You Automatically Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAII vs. The Competition Export to ExcelMetricNatural Alternatives InternationalMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.68M$1.18B$5.31B$7.35BDividend YieldN/AN/A5.45%4.31%P/E Ratio-2.0910.0421.9417.82Price / Sales0.149.44380.9497.68Price / CashN/A10.4038.2634.64Price / Book0.211.216.453.98Net Income-$7.22M-$56.07M$3.22B$247.81M7 Day Performance-7.72%5.88%5.85%3.19%1 Month Performance-25.59%-8.03%-9.55%-7.70%1 Year Performance-59.73%-40.03%11.83%1.49% Natural Alternatives International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAIINatural Alternatives International1.2491 of 5 stars$2.69-2.2%N/A-59.7%$16.68M$121.85M-2.09290Analyst ForecastShort Interest ↓News CoverageGap UpHigh Trading VolumeCRBUCaribou Biosciences2.3736 of 5 stars$0.80-8.5%$10.33+1,191.3%-80.9%$74.42M$9.99M-0.48100Analyst RevisionNews CoverageXCURExicure2.0296 of 5 stars$11.73+1.3%N/A+1,404.5%$74.11M$500,000.00-5.6750Short Interest ↓News CoverageGap UpEPIXESSA Pharma2.5724 of 5 stars$1.65+4.4%$9.50+475.8%-71.7%$73.24MN/A-2.3950UNCYUnicycive Therapeutics2.6897 of 5 stars$0.61+11.4%$5.25+760.7%-43.9%$73.02M$680,000.00-0.639SGMTSagimet Biosciences2.1224 of 5 stars$2.38+3.0%$22.40+841.2%-44.9%$73.01M$2M-1.668Gap UpADAGAdagene2.3738 of 5 stars$1.52-0.7%$8.00+426.3%-42.0%$72.08M$103,204.000.00260Short Interest ↑Gap UpADVMAdverum Biotechnologies3.7029 of 5 stars$3.43flat$27.83+711.5%-74.2%$71.35M$1M-0.57190Earnings ReportAnalyst ForecastNews CoverageIGMSIGM Biosciences3.1016 of 5 stars$1.19-0.8%$5.50+362.2%-83.1%$71.13M$2.68M-0.33190News CoverageLXEOLexeo Therapeutics3.0349 of 5 stars$2.14+8.1%$22.20+937.4%-77.5%$71.04M$650,000.00-0.6858CRBPCorbus Pharmaceuticals3.1189 of 5 stars$5.80-4.0%$59.13+919.4%-84.6%$70.95MN/A-1.2440News Coverage Related Companies and Tools Related Companies Caribou Biosciences Competitors Exicure Competitors ESSA Pharma Competitors Unicycive Therapeutics Competitors Sagimet Biosciences Competitors Adagene Competitors Adverum Biotechnologies Competitors IGM Biosciences Competitors Lexeo Therapeutics Competitors Corbus Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAII) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natural Alternatives International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natural Alternatives International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.